108
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effects of Different Systolic Blood Pressure Targets on Myocardial Function: A One-Year Follow-Up in Geriatric Hypertension

, , &
Pages 3775-3785 | Published online: 23 Jul 2021

References

  • Rahimi K, Emdin CA, MacMahon S. The epidemiology of blood pressure and its worldwide management. Circ Res. 2015;116(6):925–936. doi:10.1161/CIRCRESAHA.116.304723
  • Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. doi:10.1016/S0140-6736(15)01225-8
  • Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572. doi:10.1001/jama.289.19.2560
  • Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356(9246):1955–1964. doi:10.1016/s0140-6736(00)03307-9
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
  • Reboussin DM, Allen NB, Griswold ME, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):2176–2198. doi:10.1016/j.jacc.2017.11.004
  • Hua Q, Fan L, Jing L. Joint committee for guideline revision. 2019 Chinese guideline for the management of hypertension in the elderly. J Geriatr Cardiol. 2019;16(2):67–99. doi:10.11909/j.issn.1671-5411.2019.02.001
  • Wright JT Jr, Williamson JD, Whelton PK, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116. doi:10.1056/NEJMoa1511939
  • Ma S MD, Jd W MD. New guidelines and SPRINT results implications for geriatric hypertension. Circulation. 2019;140:976–978. doi:10.1161/CIRCULATIONAHA.119.037872
  • Rocco MV, Sink KM, Lovato LC, et al.; SPRINT Research Group. Effects of intensive blood pressure treatment on acute kidney injury events in the systolic blood pressure intervention trial (SPRINT). Am J Kidney Dis. 2018;71(3):352–361. doi:10.1053/j.ajkd.2017.08.021
  • Jones CD, Loehr L, Franceschini N, et al. Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Hypertension. 2012;59(5):913–918. doi:10.1161/HYPERTENSIONAHA.111.188151
  • Schmieder RE, Messerli FH, Sturgill D, Garavaglia GE, Nunez BD. Cardiac performance after reduction of myocardial hypertrophy. Am J Med. 1989;87:22–27. doi:10.1016/S0002-9343(89)80478-4
  • Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on LV mass in elderly patients. N Engl J Med. 1990;322:1350–1356. doi:10.1056/NEJM199005103221904
  • D’Amato A, Mancusi C, Losi MA, et al. Target organ damage and target systolic blood pressure in clinical practice: the Campania salute network. Am J Hypertens. 2018;31(6):658–664. doi:10.1093/ajh/hpy007
  • Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37(15):1196–1207. doi:10.1093/eurheartj/ehv529
  • Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16(6):577–605. doi:10.1093/ehjci/jev076
  • Lang RM, Bierig M, Devereux RB, et al; American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79–108. doi:10.1016/j.euje.2005.12.014
  • Schulman DS, Flores AR, Tugoen J, Dianzumba S, Reichek N. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function. Am J Cardiol. 1996;78:56–60. doi:10.1016/S0002-9149(96)00227-5
  • Fouad FM. Cardiac function and dysfunction in hypertension. Cleve Clin J Med. 1994;61(5):351–355. doi:10.3949/ccjm.61.5.351
  • Ishizu T, Seo Y, Kameda Y, et al. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension. 2014;63(3):500–506. doi:10.1161/HYPERTENSIONAHA.113.02149
  • Murai D, Yamada S, Hayashi T, et al. Relationships of left ventricular strain and strain rate to wall stress and their afterload dependency. Heart Vessels. 2017;32(5):574–583. doi:10.1007/s00380-016-0900-4
  • Biering-Sorensen T, Biering-Sorensen SR, Olsen FJ, et al. Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen city heart study. Circ Cardiovasc Imaging. 2017;10:e005521. doi:10.1161/CIRCIMAGING.116.005521
  • Yano M, Kohno M, Kobayashi S, et al. Influence of timing and magnitude of arterial wave reflection on left ventricular relaxation. Am J Physiol Heart Circ Physiol. 2001;280(4):H1846–H1852. doi:10.1152/ajpheart.2001.280.4.H1846
  • Kang SJ, Lim HS, Choi BJ, et al. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr. 2008;21(8):907–911. doi:10.1016/j.echo.2008.01.015
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. doi:10.1016/j.echo.2014.10.003
  • Nakamura N, Hirata K, Imanishi T, et al. Electrocardiographic strain and endomyocardial radial strain in hypertensive patients. Int J Cardiol. 2011;150(3):319–324. doi:10.1016/j.ijcard.2010.04.049
  • Duan F, Xie M, Wang X, et al. Preliminary clinical study of left ventricular myocardial strain in patients with non-ischemic dilated cardiomyopathy by three-dimensional speckle tracking imaging. Cardiovasc Ultrasound. 2012;10:8. doi:10.1186/1476-7120-10-8
  • Barbosa MM, Manoel O, Rocha C, et al. Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in chagas’disease. Echocardiography. 2014;31(5):623–630. doi:10.1111/echo.12426
  • Michel MC, Foster C, Brunner HR, Liu L. A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev. 2013;65(2):809–848. doi:10.1124/pr.112.007278
  • Raptis AE, Markakis KP, Mazioti MC, et al. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension. Am J Hypertens. 2015;28(1):22–29. doi:10.1093/ajh/hpu119
  • Levy BI, Michel JB, Salzmann JL, Devissaguet M, Safar ME. Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats. Am J Hypertens. 1991;4(3 Pt 2):240S–245S. doi:10.1093/ajh/4.3.240s
  • Ripley DP, Negrou K, Oliver JJ, et al. Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study. Clin Exp Hypertens. 2015;37(4):308–316. doi:10.3109/10641963.2014.960974
  • Burke RM, Lighthouse JK, Mickelsen DM, Small EM. sacubitril/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts. Circ Heart Fail. 2019;12(4):e005565. doi:10.1161/CIRCHEARTFAILURE.118.005565
  • Regitz-Zagrosek V, Neuss M, Holzmeister J, Fleck E. Use of angiotensin II antagonists in human heart failure: function of the subtype 1 receptor. J Hypertens Suppl. 1995;13(1):S63–S71. doi:10.1097/00004872-199507001-00010
  • Ostroumova OD, Kochetkov AI. Effects of amlodipine/lisinopril fixed-dose combination on severity of left ventricular hypertrophy and parameters of myocardial stiffness in patients with hypertension. Kardiologiia. 2016;56(11):27–37. doi:10.18565/cardio.2016.11.27-37